1. Home
  2. VSTS vs KROS Comparison

VSTS vs KROS Comparison

Compare VSTS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$6.87

Market Cap

996.9M

Sector

N/A

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$21.50

Market Cap

565.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
KROS
Founded
1936
2015
Country
United States
United States
Employees
18150
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.9M
565.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VSTS
KROS
Price
$6.87
$21.50
Analyst Decision
Sell
Buy
Analyst Count
4
15
Target Price
$5.95
$22.20
AVG Volume (30 Days)
3.2M
1.1M
Earning Date
01-30-2026
11-05-2025
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$2,734,839,000.00
$246,718,000.00
Revenue This Year
$1.47
$6,876.34
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
$13.66
Revenue Growth
N/A
37798.31
52 Week Low
$3.98
$9.12
52 Week High
$16.68
$22.55

Technical Indicators

Market Signals
Indicator
VSTS
KROS
Relative Strength Index (RSI) 59.60 72.63
Support Level $7.10 $20.73
Resistance Level $7.70 $22.20
Average True Range (ATR) 0.46 0.96
MACD 0.03 0.20
Stochastic Oscillator 69.09 83.45

Price Performance

Historical Comparison
VSTS
KROS

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: